Predictive Oncology (POAI) to Release Quarterly Earnings on Tuesday

Predictive Oncology (NASDAQ:POAI) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 13th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $1.50 million for the quarter.

Predictive Oncology Stock Performance

Predictive Oncology stock opened at $1.11 on Monday. The stock’s 50 day simple moving average is $1.13 and its two-hundred day simple moving average is $1.10. The stock has a market cap of $9.91 million, a price-to-earnings ratio of -0.36 and a beta of 1.30. Predictive Oncology has a fifty-two week low of $0.55 and a fifty-two week high of $3.06.

About Predictive Oncology

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.